M. Liang

Efficacy and safety of benazepril for advanced chronic renal insufficiency.

Di Xie, Ping-yan Chen, F. Hou, 2006, The New England journal of medicine.

Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy

M. Liang, N. Fu, Shicheng Yang, 2017, Medicine.

High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention

M. Liang, N. Fu, Shicheng Yang, 2018, Angiology.

Efficacy of alprostadil in preventing contrast‐induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial

M. Liang, Chengzhi Lu, N. Fu, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.

W. Poon, M. Liang, G. Wong, 2013, Neurosurgery.

High-Dose Simvastatin for Aneurysmal Subarachnoid Hemorrhage: Multicenter Randomized Controlled Double-Blinded Clinical Trial

B. Zee, W. Poon, M. Chan, 2015, Stroke.

Characteristics and long‐term prognosis of patients with reduced, mid‐range, and preserved ejection fraction: A systemic review and meta‐analysis

M. Liang, B. Bian, Qing Yang, 2022, Clinical cardiology.

Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention

M. Liang, Zhen-hua Ma, H. Cong, 2018, Angiology.

The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study

M. Liang, Hongliang Cong, Chengzhi Lu, 2017, International Urology and Nephrology.